X @The Wall Street Journal
The Wall Street Journal·2026-04-27 11:53
Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer portfolio. https://t.co/0G3YkcilV8 ...